什麼會損害或殺死植髮毛囊？

植髮的成功與否取決於毛囊存活率

Home » 什麼會損害或殺死植髮毛囊？

專注植髮 20 年：每一過程均由香港註冊醫生親自監管主理

甚麼是毛囊存活率?

植髮的成功與否取決於毛囊存活率——即移植後能永久生長的毛囊百分比。毛囊是活體組織，可能因人為失誤（H 因素）與生物性壓力源（X 因素）而受損或壞死。一旦毛囊受損，便無法再生。保護毛囊需要在每個階段都做到：細緻的手術技術、嚴格的無菌流程，以及患者精確的術後護理。

損害或殺死毛囊的兩大主因為：「H 因素」（人為／程序錯誤）與「X 因素」（生物性壓力源）。這些問題可能發生在提取、保存、植入或癒合的任何階段。由於人一生的供體毛囊總數固定且不可替代，因此最大化存活率是倫理植髮的最高目標。

Sara 點評

人自出生後，不會再新增毛囊。手術的每個步驟都應精心設計，以最大化毛囊存活率，確保每個移植的毛囊都有最佳機會健康生長、維持終生。

何謂「X 因素」（生物性壓力源）？

X 因素是亞臨床生物性損傷，未必肉眼可見，卻會損害毛囊存活率。目前，大多數不明原因的生長不良皆由此導致。

再灌注損傷：血液供應重新建立時，毛囊因氧化作用受損。
過熱與脫水：術後關鍵首週，在新血液循環穩定之前發生。
微發炎：過度或延長的發炎反應，傷害毛囊健康。
自體排斥：移植組織引發的罕見免疫反應。

何謂「H 因素」（人為／程序錯誤）？

H 因素指因違反手術程序，或患者未遵指引所造成的可預防損傷。

術前 H 因素：潛在體質或生活習慣風險

受區血液循環不良：疤痕或血管問題，影響移植區血流。
健康狀況未受控：吸菸、糖尿病失控或營養不良，妨礙癒合。

術中 H 因素（最關鍵階段）

脫水：毛囊暴露空氣中，未能充分保濕。
物理創傷：毛囊受擠壓、切割或過度碰觸。
儲存不當：使用非生理性保存液或極端溫度（低溫損傷）。
體外時間過長：毛囊植入前離開身體太久。

術後 H 因素：

患者未遵指引：未按術後指示照顧（如搔抓、曝曬、劇烈活動）。
物理創傷：受區直接受外力撞擊。
感染：傷口護理不當，導致毛囊炎。

為何毛囊存活率是最重要的指標？

供體資源有限：您擁有的永久性供體毛囊數量固定且不可再生。浪費即是永久損失。
直接影響最終效果：存活率決定密度。研究顯示，至少 85% 存活率方能達到理想美觀效果。
影響未來手術與疤痕：首次手術存活率高，能為將來保留更多供體毛囊，並可能縮小 FUT 取髮疤痕。
決定真實成本：診所按移植毛囊數收費，而非按成功生長數。低存活率將大幅提高每根存活毛囊的真實成本。

對比分析：低存活率的隱形成本

中心A（損傷率20%）：每根存活毛囊實際支付 31 美元。
中心B（損傷率2%）：每根存活毛囊實際支付 25.5美元。
結論：技術水平較低（切割/損傷率較高）的診所，實際上更昂貴，因為您為未能生長的毛囊付費。

健康毛囊如何癒合與重建血供？

了解此生物過程，方能明白技術為何至關重要。

第 1-3 天：毛囊處於缺血期，依靠擴散作用存活。發炎反應開始。
第 3-7 天：重建血供的關鍵期（新血管形成）。嗜中性球與巨噬細胞活躍。
第 2-4 週：發炎細胞消退；纖維母細胞與膠原蛋白穩定毛囊。
第 1-3 個月：毛囊進入新生長週期，通常會脫落原有毛幹，再長出新髮。

我們如何最大化毛囊存活率？

我們的方案旨在系統性減少 H 因素與 X 因素。

術前優化：醫療評估與患者指導，提升頭皮健康。
手術精準度：使用高倍顯微鏡、冷藏生理保存液與精密器械，以減少創傷與脫水。
訓練有素的協調團隊：更熟練的操作可縮短毛囊體外時間。我們追求高效進行大數量移植，而非倉促了事。
詳盡術後護理計畫：提供清潔、活動與監測的具體指引，保護脆弱癒合期的毛囊。

關鍵要點：

毛囊不可替代：受損毛囊無法再生或複製。存活率是倫理手術的基石。
兩大殺手：H 因素與 X 因素：失敗原因來自人為/程序錯誤（H）或生物性損傷（X）。專業團隊致力減少兩者。
存活率決定真實價值：真實成本按每根存活毛囊計算。高切割率的「廉價」診所，長期往往更昂貴。
首週最為關鍵：手術期間及術後血供重建完成前，是毛囊最脆弱時期。
技術重於速度：遵循最佳方案、精準細緻的團隊，比快速流水線作業，能實現更高存活率。

您的下一步：了解我們的存活率保障方案

選擇醫生，即是選擇您有限供體毛囊的守護者。 諮詢時請詢問我們關於毛囊存活方案、保存液與平均體外時間的具體措施。 我們透明公開所有保護您最寶貴資產——供體毛囊——的方法。

毛囊存活率因個人與手術情況而異。嚴格遵守所有術前與術後指引至關重要。本資訊僅供教育目的，闡述特定手術理念。

參考書籍

Aby Mathew. A review of Cellular Bippreservation Consideration During Hair Transplantation. Hair Transplant Forum International, Vol 23 No. 1, January/February 2013
Baust, J.G. In: J.G. Baust and J.M. Baust, eds. Advances in Biopreservation. CRC Press, 2007; 1-14.
Snyder, K.K., et al. Biological packaging for the global cell and tissue therapy markets. BioProcessing Journal. 2004(May/June); 1-7.
Reyes, A.B., J.S. Pendergast, and S. Yamazaki. Mammalian peripheral circadian oscillators are temperature compensated. J Biol Rhythms. 2008; 23:95-98.
Allen, F.M. Physical and toxic factors in shock. Archives of Surgery. 1939; 38:155-180.
Bigelow, W.G., W.K. Lindsay, and W.F. Greenwood. Hypothermia: its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperature. Annals of Surgery. 1950; 132:849-866.
Swan, H., et al. Hypothermia in surgery: analysis of 100 clinical cases. Annals of Surgery. 1955; 142:382-400.
Collins, G.M., M. Bravo-Shugarman, and Pl. Terasaki. Kidney preservation for transplantation: initial perfusion and 30 hours ice storage. Lancet. 1969; 2:1219.
Taylor, M.J., et al. A new solution for life without blood: asanguineous low ﬂow perfusion of a whole-body perfusate during 3 hours of cardiac arrest and profound hypothermia. Circulation. 1995; 91:431-444.
Van Buskirk, R.G., et al. Assessment of hypothermic storage of normal human epidermal keratinocytes (NHEK) using Alamar Blue. In Vitro Toxicology. 1996; 9:297-303.
Mathew, A.J., J.G. Baust, and R.G. Van Buskirk. Optimization of HypoThermosol for the hypothermic storage of cardiac cells—addition of EDTA. In Vitro Toxicology. 1997; 10(4):407-415.
Mathew, A.J., et al. Vitamin E and EDTA improve the efﬁcacy of HypoThermosol—implication of apoptosis. In Vitro Toxicology. 1999; 12(3):163-172.
Dahdah, N.S., et al. Effects of HypoThermosol, an experimental acellular solution for tissue preservation and cardiopulmonary bypass, on isolated newborn lamb coronary vessels subjected to ultraprofound hypothermia and anoxia. Cryobiology. 1999; 39:58-68.
Mathew, A.J., J.G. Baust, and R.G. Van Buskirk. Improved hypothermic preservation of human renal cells through suppression of both apoptosis and necrosis. Cell Preservation Technology. 2003; 1:239-254.
Baust, J.M., et al. Transplantation diagnostics: utilization of protein microarray analysis to determine kidney status and transplantation efﬁcacy. Cell Preservation Technology. 2004; 2(2):81.
Mathew, A.J., et al. Cell preservation in reparative and regenerative medicine: evolution of individualized solution composition. Tissue Engineering. 2004; 10:1662-1671.
Snyder, K.K., et al. Biological packaging for the global cell and tissue therapy markets. BioProcessing Journal. 2004; 3(3):39.
Van Buskirk, R.G., et al. Hypothermic storage and cryopreservation: the issues of successful short-term and long term preservation of cells and tissues. BioProcess Int’l. 2004; 2(10):42.
Baust, J.M. Advances in media for cryopreservation and storage. BioProcess International. 2005; 3:46-56.
Snyder, K.K., et al. Enhanced hypothermic storage of neonatal cardiomyocytes. Cell Preservation Technology. 2005; 3(1):61-74.
Mathew, A.J. I’m losing cell viability and function at different points in my process, and I don’t know why! BioProcess Int’l. 2010; 8(6) 54-7.
Ikonomovic, M., et al. Ultraprofound cerebral hypothermia and blood substitution with an acellular synthetic solution maintains neuronal viability in rat hippocampus. CryoLetters. 2001; 22:19-26.
Lodish, H.F., et al. Transport across cell membranes. In: S. Tenney, ed. Molecular Cell Biology. 4th Edition. New York: W.H. Freeman, 2000; 590-591.
MacKnight, A.D.C., and A. Leaf. Regulation of cellular volume. Physiology Review. 1977; 57:510.
Martin, D.R., et al. Primary cause of unsuccessful liver and heart preservation: cold sensitivity of the ATPase system. Annals of Surgery. 1972; 175:11.
Boutilier, R.G. Mechanisms of cell survival in hypoxia and hypothermia. J of Experimental Biology. 2001; 204:3171-3181.
Toledo-Pereyra, L.H., A.J. Paez-Rollys, and J.M. PalmaVargas. Science of organ preservation. In: L.H. ToledoPereyra, ed. Organ Procurement and Preservation for Transplantation. Landes Bioscience, 1997; 1-16.
Rehncrona, S., B.K. Siesjo, and D.S. Smith. Reversible ischemia of the brain: biochemical factors inﬂuencing restitution. ActaPhysioliogy Scandinavia. 1979; Suppl 492:135.
Cotterill, P. ISHRS survey majority using chilled saline. W. Reed Personal communication, December 2012. Reed, W. Personal communication, December 2012.
Perez-Meza, D., M. Leavitt, and M. Mayer. The growth factors. Part 1: clinical and histological evaluation of the wound healing and revascularization of the hair graft after hair transplant surgery. Hair Transplant Forum Int’l. 2007; 17(5):173.
Perez-Meza D. Wound healing and revascularization of the hair transplant graft: role of the growth factors. In: W. Unger and R. Shapiro, eds. Hair Transplantation, 4th Ed. Marcel Dekker, New York, 2004; 287-294.
Cooley, J. Ischemia-reperfusion injury and graft storage solutions. Hair Transplant Forum Int’l. 2004; 14(4):121,127,130.
Parsley, W.M., and D. Perez-Meza. Review of factors affecting the growth and survival of follicular grafts. J Cutan Aesthet Surg. 2010; 3(2):69-75.
Limmer, R. Micrograft survival. In: D. Stough, ed. Hair Replacement. Mosby Press, 1996; 147-149.
Kim, J.C., and S. Hwang. The effects of dehydration, preservation temperature and time, and hydrogen peroxide on hair grafts. In: W.P. Unger and R. Shapiro, eds. Hair Transplantation, 4th Ed. New York: Marcel Dekker, 2004; 285-286.
Hwang, S.J., et al. The effects of dehydration, preservation temperature and time on the hair grafts. Annals of Dermatology. 2002; 14:149-152. 37. Krugluger, W., et al. Enhancement of in vitro hair shaft elongation in follicles stored in buffers that prevent follicle cell apoptosis. Dermatol Surg. 2004; 30:1-5.
Krugluger, W., et al. New storage buffers for micrografts enhance graft survival and clinical outcome in hair restoration surgery. Hair Transplant Forum Int’l. 2003; 13(3):333-334.
Van Buskirk, R.G., et al. Navigating the post-preservation viability fog: assay standardization for cell and tissue therapy applications. Genetic Engineering News. 2006; 26(19):38-39.
Van Buskirk, R. Viability and functional assays used to assess preservation efﬁcacy: the multiple endpoint/tier approach. In: J.G. Baust and J.M. Baust, eds. Advances in Biopreservation. CRC Press-Taylor and Francis Publishing: New York, 2006.
Belzer, F., and J. Southard. Principles of solid-organ preservation by cold storage. Transplantation. 1988; 45(4):673-676.
Taylor, M.J. The role of pH and buffer capacity in the recovery of function of smooth muscle cooled to –13°C in unfrozen media. Cryobiology. 1982; 19:585-60.
Taylor, M.J., and Y. Pignat. Practical acid dissociation constants, temperature coefﬁcients and buffer capacities for some biological buffers in solutions containing dimethyl sulfoxide between 25 and –12°C. Cryobiology. 1982; 19:99-109.
Fujita, J. Cold shock response in mammalian cells. J Mol Microbiol Biotechnol. 1999; 1(2):243-255.
Plesnila, N., et al. Effect of hypothermia on the volume of rat glial cells. Journal of Physiology. 2000; 523.1:155-162.
Tseng, Y-C, et al. Exploring uncoupling proteins and antioxidant mechanisms under acute cold exposure in brains of ﬁsh. PLoS ONE. 2011; 6(3):1-15.
Corwin, W.L., et al. The unfolded protein response in human corneal endothelial cells following hypothermic storage: Implications of a novel stress pathway. Cryobiology. 2011; 63(1):46-55.
Baust, J.M. Overview of hypothermic storage. Hair Transplant Forum Int’l. 2006; 16(2):53.
Cosentino, L.M., et al. Preliminary report: evaluation of storage conditions and cryococktails during peripheral blood mononuclear cell cryopreservation. Cell Preservation Technology. 2007; 5:189-204.
Baust, J.M., R.G. Van Buskirk, and J.G. Baust. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell and Developmental Biology. 2000; 36:262.
Baust, J.M., et al. A molecular basis of cryopreservation failure and its modulation to improve cell survival. Cell Transplantation. 2001; 10:561.
Baust, J.M., R.G. Van Buskirk, and J.G. Baust. Gene activation of the apoptotic caspase cascade following cryogenic storage. Cell Preservation Technology. 2002; 1:63.
• Baust, J.M. Molecular mechanisms of cellular demise associated with cryopreservation failure. Cell Preservation Technology. 2002; 1:17.
Anderson, R.V., M.G. Siegman, and R.S. Balaban. Hyperglycemia increases cerebral intracellular acidosis during circulatory arrest. Annals of Thoracic Surgery. 1992; 54:1126-1130.
Ely, S.W., and R.M. Berne. Protective effects of adenosine in myocardial ischemia. Circulation. 1992; 85:893-904.
Bessems, M., et al. Preservation of rat livers by cold storage: a comparison between the University of Wisconsin solution and HypoThermosol. Ann Transplant. 2004; 9(2):35-37.
Povsic, T., et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. American Heart Journal. 2011; 162(4):654-662.
Powell, R., et al. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia. J of Vasc Surg.2011; 54(4):1032-1041.
Ginis, I., B. Grinblat, and M. Shirvan. Evaluation of bone marrow-derived mesenchymal stem cells after cryopreservation and hypothermic storage in clinically safe medium. Tissue Engineering Part C Methods. 2012; 18(6):453-463.
Lowe, N.J., P.L. Lowe, and J. St Clair Roberts. A phase IIa open-label dose-escalation pilot study using allogeneic human dermal ﬁbroblasts for nasolabial folds. Dermatol Surg. 2010; 36(10):1578-1585.
Raposio, E., et al. Effects of cooling micrografts in hair transplantation surgery. Dermatol Surg. 1999; 25:705-707.
• Jiange, Q., et al. How long can hair follicle units be preserved at 0 and 4°C for delayed transplant? Dermatol Surg. 2005; 31:23-26.
Kurata, S., et al. Viability of isolated single hair follicles preserved at 4°C. Dermatol Surg. 1999; 25:26-29.
Beehner, M.L. Notes from the Editor Emeritus. Hair Transplant Forum Int’l. 2005; 15(6):193-195.
Cooley, J.E. Successful extended storage of hair follicles using hypothermic media with liposomal ATP. Translational Regenerative Medicine Forum. 2010.
Beehner, M.L. 96-hour study of FU graft “out-of-body” survival comparing saline to HypoThermosol/ATP solution. Hair Transplant Forum Int’l. 2011; 21(2):1, 37.
Ehringer, W.D. New horizons in storage solutions and additive agents in organ transplantation. Norwood Lecture, ISHRS 2011 Annual Scientiﬁc Meeting.

網頁使用 - 醫學免責聲明

所示圖片與資訊僅供個人參考

所有內容僅作為一般教育用途，不構成個人化醫療建議，亦非用以宣傳本中心服務或暗示其優越性。

植髮效果因人而異，無法保證特定結果。所展示的術前術後照片僅代表可能成效，而非承諾。建議您尋求獨立醫療意見，以充分了解個人選項…… 閱讀詳細內容

術前免費線上諮詢評估

初步確認您是否適合植髮

若您不適合植髮，何必要白付醫生診金？本中心「無悔植髮」流程的第一步，應先從免費的 WhatsApp 線上評估開始 – 助您判斷植髮是否解決閣下脫髮問題的合理選擇。

仍有疑問？

若希望獲得本中心醫療團隊針對您個人情況提供意見，歡迎透過下方表單聯絡我們。我們將盡快與您聯繫。

美絲植髮品質與安全標準

本中心嚴格遵循國際植髮組織所制定的臨床指引：

ISHRS 國際植髮醫學會

ISHRS 是制定國際植髮技術標準與患者安全規範的最具權威植髮醫學協會。

ABHRS 美國植髮認證委員會

ABHRS 代表全球植髮領域最高專業認證標準，醫師必須通過考核才能獲取會員資格。

WFI 世界微創技術研究院

WFI 專注於研發、改良、監察、以及推廣 FUE 微創植髮技術的國際性教育機構。